Impact of timing and dose of mesenchymal stromal cell therapy in a preclinical model of acute myocardial infarction.
Richardson JD, Bertaso AG, Psaltis PJ, Frost L, Carbone A, Paton S, Nelson AJ, Wong DT, Worthley MI, Gronthos S, Zannettino AC, Worthley SG.
Richardson JD, et al. Among authors: worthley sg, worthley mi.
J Card Fail. 2013 May;19(5):342-53. doi: 10.1016/j.cardfail.2013.03.011.
J Card Fail. 2013.
PMID: 23663817